McVicar William K. 4
4 · Salarius Pharmaceuticals, Inc. · Filed Mar 25, 2020
Insider Transaction Report
Form 4
McVicar William K.
President, R&D
Transactions
- Award
Common Stock
2020-03-23+6,000→ 6,000 totalExercise: $0.61Exp: 2030-03-22→ Stock Option (right to buy) (6,000 underlying)
Footnotes (1)
- [F1]Options granted are fully vested on March 23, 2021.